• 1st June 2018

    Committee for Medicinal Products for Human Use adopts positive opinion for use of Aimovig in migraine prevention

    The European Medicines Agency will now consider this guidance

    Read more
  • 24th May 2018

    First preventive migraine treatment launches in the US

    The Migraine Trust is hoping that it will be approved in the UK in the near future

    Read more
  • 14th May 2018

    People who get migraine are more likely to struggle with their mental health

    The Migraine Trust is urging anyone who is struggling with their mental health to seek help

    Read more
  • 25th April 2018

    New report reveals impact of migraine on the UK economy

    Report calls on government and national bodies to develop strategy for improving migraine care across employment and health systems

    Read more
  • 26th March 2018

    New restrictions on valproate use in pregnancy

    An update from the Medicines and Healthcare products Regulatory Agency (MHRA)

    Read more